Reporting of side effects:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

Bladder Cancer Care

Your body has a huge number of cells, over 200 different types. They all work together to provide the structure of the body, its organs and tissues and a multitude of different functions. Cells regularly divide and make new cells, to enable the body to heal, repair and grow. Cancer starts when one cell becomes abnormal and starts to grow or multiply in an uncontrolled way. These abnormal cells form a lump or tumour and some of these tumours may be cancerous.

Bladder cancer is quite common with over 21,000 people being diagnosed each year in the UK1.

This video helps explain the symptoms and treatments

Non-muscle invasive bladder cancer NMIBC

Developed alongside Action Bladder Cancer UK (ABC UK), this booklet has been written as a short introduction to non-muscle invasive bladder cancer – NMIBC (sometimes referred to as early or superficial bladder cancer). It is intended to give you more information following a suspected diagnosis and help you understand the basics of bladder cancer, how it is tested and graded, the main treatment options and where you can find more support.

Mitomycin medac – what to expect during your bladder cancer treatment

If you are a patient who’s been prescribed Mitomycin medac, click below to view the ‘what to expect’ leaflet.

BCG-medac – what to expect during your bladder cancer treatment

If you are a patient who’s been prescribed BCG-medac, click below to view the ‘what to expect’ leaflet

References:

  1.  https://www.fightbladdercancer.co.uk/get-help/what-bladder-cancer – Last accessed March 2026

Copyright © medac Pharma LLP 2022. All rights reserved.

medac Code: D060/02/2026.
Date of Preparation: March 2026

Are you a UK patient?

This information is intended for UK patients who have been prescribed Mitomycin medac or BCG-medac only.
I confirm that I am a UK patient who has been prescribed Mitomycin medac or BCG-medac.